BE737975A - - Google Patents

Info

Publication number
BE737975A
BE737975A BE737975A BE737975A BE737975A BE 737975 A BE737975 A BE 737975A BE 737975 A BE737975 A BE 737975A BE 737975 A BE737975 A BE 737975A BE 737975 A BE737975 A BE 737975A
Authority
BE
Belgium
Application number
BE737975A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE737975A publication Critical patent/BE737975A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • C07C53/136—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems
    • C07C53/138—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems containing an adamantane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/38—Acyl halides
    • C07C53/44—Acyl halides containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/36—Acyl halides
    • C07C55/38—Acyl halides containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pivots And Pivotal Connections (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
BE737975A 1968-08-27 1969-08-26 BE737975A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40968/68A GB1274652A (en) 1968-08-27 1968-08-27 Adamantanyl-alkylamine derivatives and their preparation

Publications (1)

Publication Number Publication Date
BE737975A true BE737975A (de) 1970-02-26

Family

ID=10417493

Family Applications (1)

Application Number Title Priority Date Filing Date
BE737975A BE737975A (de) 1968-08-27 1969-08-26

Country Status (12)

Country Link
JP (3) JPS4939257B1 (de)
AT (1) AT307380B (de)
BE (1) BE737975A (de)
CH (3) CH553149A (de)
DE (1) DE1943404A1 (de)
DK (1) DK131721C (de)
FR (1) FR2016468B1 (de)
GB (1) GB1274652A (de)
IE (1) IE33929B1 (de)
IL (1) IL32892A (de)
NL (1) NL6913046A (de)
SE (1) SE364037B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS507356A (de) * 1973-05-22 1975-01-25
GB0013737D0 (en) 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
SE0103836D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
SE0300480D0 (sv) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
ITTO20030668A1 (it) 2003-09-02 2005-03-03 Rotta Res Lab S P A O Ra Rottapharm Derivati dell'adamantano dotati di attivita' neuroprotettiva, antidepressiva e anti-ischemica e procedimento per la loro preparazione.
RU2460727C2 (ru) 2007-03-22 2012-09-10 Астразенека Аб Хинолиновые производные для лечения воспалительных заболеваний
PE20091036A1 (es) 2007-11-30 2009-08-15 Astrazeneca Ab Derivado de quinolina como antagonista del receptor p2x7
CN109593042B (zh) * 2018-12-24 2021-12-07 陕西莱特迈思光电材料有限公司 一种有机电致发光材料及包含其的有机电致发光器件
CN114181091B (zh) * 2021-12-27 2024-06-14 维思普新材料(苏州)有限公司 一种金刚烷三苯胺的合成工艺
CN116947644B (zh) * 2023-07-26 2025-01-24 山东轩鸿生物医药有限公司 一种盐酸美金刚的制备方法

Also Published As

Publication number Publication date
GB1274652A (en) 1972-05-17
FR2016468B1 (de) 1973-06-08
FR2016468A1 (de) 1970-05-08
NL6913046A (de) 1970-03-03
SE364037B (de) 1974-02-11
JPS4939257B1 (de) 1974-10-24
DK131721C (da) 1976-01-26
CH553149A (fr) 1974-08-30
CH538442A (fr) 1973-06-30
IL32892A0 (en) 1969-11-12
JPS5010856B1 (de) 1975-04-24
AT307380B (de) 1973-05-25
JPS4939256B1 (de) 1974-10-24
DE1943404A1 (de) 1970-12-17
DK131721B (da) 1975-08-25
IE33929B1 (en) 1974-12-11
IL32892A (en) 1975-04-25
IE33929L (en) 1970-02-27
CH551365A (fr) 1974-07-15

Similar Documents

Publication Publication Date Title
AU1946070A (de)
AU428130B2 (de)
AU2374870A (de)
AU5184069A (de)
FR2016468B1 (de)
AU6168869A (de)
AU429879B2 (de)
AU4811568A (de)
AU421558B1 (de)
AR203075Q (de)
AU2580267A (de)
AU3224368A (de)
AU3789668A (de)
AU4744468A (de)
AU4270368A (de)
BE642636A (de)
BE709095A (de)
AU4224469A (de)
BE581157A (de)
BE708933A (de)
AU2496167A (de)
BE728692A (de)
AU2889368A (de)
AU4558658A (de)
BE728390A (de)